Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 14, 2024
Initial Data from Ongoing MyPEAK™-1 Phase 1b of TN-201 Expected in Second Half of 2024
Clinical Sites Activated for RIDGE™-1 Phase 1b Clinical Trial of TN-401
Read more at globenewswire.com
